Citation: Z. Laron, RESPONSE TO EUROPEAN-JOURNAL-OF-ENDOCRINOLOGY 1997 137 459-466 AND 450-452 - EFFECT OF GH ON LIPOPROTEIN(A) IN GH DEFICIENCY, European journal of endocrinology, 138(4), 1998, pp. 440-440
Citation: Z. Laron et B. Klinger, EFFECT OF INSULIN-LIKE GROWTH-FACTOR-I TREATMENT ON SERUM ANDROGENS AND TESTICULAR AND PENILE SIZE IN MALES WITH LARON SYNDROME (PRIMARY GROWTH-HORMONE RESISTANCE), European journal of endocrinology, 138(2), 1998, pp. 176-180
Citation: Z. Laron et al., SERUM LEPTIN IN OBESE PATIENTS WITH LARON-SYNDROME BEFORE AND DURING IGF-I TREATMENT, Journal of pediatric endocrinology & metabolism, 11(5), 1998, pp. 653-656
Citation: J. Ye et al., LACK OF SEASONALITY IN THE MONTH OF ONSET OF CHILDHOOD IDDM (0.7-15 YEARS) IN SHANGHAI, CHINA, Journal of pediatric endocrinology & metabolism, 11(3), 1998, pp. 461-464
Citation: Z. Laron et G. Bolli, DIABETES IN THE YOUNG - ISPAD WORKSHOP ON HYPOGLYCEMIA HELD IN STOCKHOLM, SWEDEN, JUNE 1997 - FOREWORD, Journal of pediatric endocrinology & metabolism, 11, 1998, pp. 97-97
Authors:
KLINGER B
ANIN S
SILBERGELD A
ESHET R
LARON Z
Citation: B. Klinger et al., DEVELOPMENT OF HYPERANDROGENISM DURING TREATMENT WITH INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) IN FEMALE-PATIENTS WITH LARON-SYNDROME, Clinical endocrinology, 48(1), 1998, pp. 81-87
Authors:
ZEEVI B
GILAD I
ZABRESKI R
BERANT M
LARON Z
WEIZMAN A
BLIEDEN LC
Citation: B. Zeevi et al., INTERVENTIONAL CATHETERIZATION DECREASES PLASMA-LEVELS OF ATRIAL-NATRIURETIC-PEPTIDE (ANP) IN CHILDREN WITH CONGENITAL HEART-DEFECTS, Catheterization and cardiovascular diagnosis, 45(1), 1998, pp. 27-32
Authors:
ATTANASIO A
ATTIE K
BAXTER R
BENGTSSON BA
BLACK A
BLETHEN S
CARLSSON L
CASANEUVA F
CHIPMAN J
CHRISTIANSEN JS
CLEMMONS D
CUNEO R
DERIJDT D
GHIGO E
HARTMAN M
HERNBERGSTAHL E
HINTZ R
GARVAN KH
HOFFMAN D
IRIE M
JORGENSEN JO
KAPPELGAARD AM
LARON Z
MALOZOWSKI S
RUSSELLJONES D
SHALET S
SIZONENKO P
SONKSEN PH
STRASBURGER C
TAKANO K
THORNER M
Citation: A. Attanasio et al., CONSENSUS GUIDELINES FOR THE DIAGNOSIS AND TREATMENT OF ADULTS WITH GROWTH-HORMONE DEFICIENCY - SUMMARY STATEMENT OF THE GROWTH-HORMONE-RESEARCH-SOCIETY WORKSHOP ON ADULT GROWTH-HORMONE DEFICIENCY, The Journal of clinical endocrinology and metabolism, 83(2), 1998, pp. 379-381
Authors:
GREEN A
SCHOBER E
CHRISTOV V
SVENDSEN AJ
KREUTZFELDT J
LUND E
TUOMILEHTO J
BARTSOCAS C
PAPOZOGLOU N
SOLTESZ G
CHIUMELLO G
LARON Z
BRIGIS G
URBONAITE B
DEBEAUFORT C
REESER M
ABREU S
MENEZES C
PINA EA
IONESCUTIRGOVISTE C
DALQUIST G
MCKINNEY P
HADDEN D
BINGLEY P
Citation: A. Green et al., FAMILIAL RISK OF TYPE-I DIABETES IN EUROPEAN CHILDREN, Diabetologia, 41(10), 1998, pp. 1151-1156
Citation: Z. Laron et al., INVERSE RELATIONSHIP BETWEEN MONTH OF BIRTH AND MONTH OF ONSET OF IDDM IN JEWISH CHILDREN IN ISRAEL, Diabetes, 47, 1998, pp. 578-578
Authors:
KANETY H
SILBERGELD A
KLINGER B
KARASIK A
BAXTER RC
LARON Z
Citation: H. Kanety et al., LONG-TERM EFFECTS OF INSULIN-LIKE-GROWTH-FACTOR (IGF)-I ON SERUM IGF-I, IGF-BINDING PROTEIN-3 AND ACID-LABILE SUBUNIT IN LARON-SYNDROME PATIENTS WITH NORMAL GROWTH-HORMONE BINDING-PROTEIN, European journal of endocrinology, 137(6), 1997, pp. 626-630
Authors:
LARON Z
WANG XL
KLINGER B
SILBERGELD A
WILCKEN DEL
Citation: Z. Laron et al., GROWTH-HORMONE INCREASES AND INSULIN-LIKE GROWTH-FACTOR-I DECREASES CIRCULATING LIPOPROTEIN(A), European journal of endocrinology, 136(4), 1997, pp. 377-381
Authors:
KALTERLEIBOVICI O
LEIBOVICI L
LOYA N
KREMER I
AXERSIEGEL R
KARP M
LARON Z
Citation: O. Kalterleibovici et al., THE DEVELOPMENT AND PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-I DIABETIC-PATIENTS - A COHORT STUDY, Diabetic medicine, 14(10), 1997, pp. 858-866
Authors:
SILBERGELD A
DASTOT F
KLINGER B
KANETY H
ESHET R
AMSELEM S
LARON Z
Citation: A. Silbergeld et al., INTRONIC MUTATION IN THE GROWTH-HORMONE (GH) RECEPTOR GENE FROM A GIRL WITH LARON-SYNDROME AND EXTREMELY HIGH SERUM GH BINDING-PROTEIN - EXTENDED PHENOTYPIC STUDY IN A VERY LARGE PEDIGREE, Journal of pediatric endocrinology & metabolism, 10(3), 1997, pp. 265-274
Citation: Z. Laron et al., GIRLS WITH LARON-SYNDROME HAVING POSITIVE GROWTH-HORMONE BINDING-PROTEIN (GHBP) ARE LESS RETARDED IN HEIGHT THAN THOSE LACKING GHBP, Journal of pediatric endocrinology & metabolism, 10(3), 1997, pp. 305-307
Authors:
LARON Z
KLINGER B
ANIN S
PERTZELAN A
LILOS P
Citation: Z. Laron et al., GROWTH DURING AND 2 YEARS AFTER STOPPING GH TREATMENT IN PREPUBERTAL CHILDREN WITH IDIOPATHIC SHORT STATURE, Journal of pediatric endocrinology & metabolism, 10(2), 1997, pp. 191-196
Citation: Db. Dunger et al., ISPAD WORKSHOP - ROLE OF GH AND IGF-I IN CARBOHYDRATE AND LIPID-METABOLISM - DIABETES IN THE YOUNG - PREFACE, Journal of pediatric endocrinology & metabolism, 10, 1997, pp. 85-85
Citation: Z. Laron et al., INSULIN-RESISTANCE IN LARON-SYNDROME (PRIMARY INSULIN-LIKE GROWTH-FACTOR-I (IGF-I) DEFICIENCY) AND EFFECT OF IGF-I REPLACEMENT THERAPY, Journal of pediatric endocrinology & metabolism, 10, 1997, pp. 105-115
Citation: Z. Laron et al., OPPOSING EFFECTS OF GROWTH-HORMONE AND INSULIN-LIKE-GROWTH-FACTOR-I ON SERUM LIPOPROTEIN(A), Journal of pediatric endocrinology & metabolism, 10, 1997, pp. 143-149
Citation: O. Brat et al., MUSCLE FORCE AND ENDURANCE IN UNTREATED AND HUMAN GROWTH-HORMONE OR INSULIN-LIKE GROWTH FACTOR-I-TREATED PATIENTS WITH GROWTH-HORMONE DEFICIENCY OR LARON SYNDROME, Hormone research, 47(2), 1997, pp. 45-48